Quick Facts
What is HGH Fragment 176-191?
HGH Fragment 176-191 represents the tail end of the growth hormone molecule, specifically the portion responsible for fat metabolism. This synthetic fragment provides the fat-burning effects of HGH without affecting blood glucose or promoting growth. It's essentially a more targeted version of AOD-9604, which has an additional tyrosine modification. The fragment stimulates lipolysis and inhibits lipogenesis without the broader hormonal effects of full growth hormone.
How Does HGH Fragment 176-191 Work?
Fragment 176-191 mimics how natural GH regulates fat metabolism but doesn't interact with the GH receptor. It stimulates lipolysis (fat breakdown) by acting on adipocytes through mechanisms that may involve beta-3 adrenergic receptors. Unlike full GH, it doesn't cause IGF-1 elevation, blood glucose changes, or tissue growth effects.
Research-Backed Benefits
Targeted Fat Loss
Moderate EvidenceSpecifically promotes lipolysis without growth effects.
No Blood Sugar Impact
Strong EvidenceDoesn't affect glucose levels or insulin sensitivity.
No Growth Effects
Strong EvidenceWon't cause tissue growth or IGF-1 elevation.
Lipogenesis Inhibition
Moderate EvidenceMay prevent new fat formation.
Dosage Guidelines
Disclaimer: This content is for educational purposes only. Peptides are research compounds not approved by the FDA for human use. Always consult with a qualified healthcare provider.
Best taken on empty stomach. Morning and pre-workout are popular timing.
Side Effects & Safety
- Generally well tolerated
- Injection site irritation
- Possible headache
- Minimal systemic effects
Frequently Asked Questions
References
- Ng FM, et al. "GH fragment lipolytic effects." J Endocrinol, 2000. PMID: 10801956
Get the Complete HGH Fragment 176-191 Research Protocol
Join 50,000+ researchers with instant access to our comprehensive peptide resource.